The COVID-19 infection is again peaking across the globe. This time, it is triggered by the Omicron subvariant BF.7, which is believed to be highly transmissible and has a shorter incubation period. The new BF.7 sub-variant has set havoc in China, with thousands of cases reported daily. Also, countries like Japan, Argentina, South Korea, and the US are witnessing a sudden spike in COVID cases. Observing the sudden spread of coronavirus globally, the Indian government has announced stringent preventive measures and has recommended all eligible citizens get vaccine shots, including booster doses. 
COVID 19

India has been thriving in fighting the Pandemic and has always been at the forefront of formulating medicines and vaccines to curb the spread of coronavirus. In another revolutionary and historic event, the Government of India has approved using nasal vaccines as booster doses. Bharat Biotech has developed the intranasal COVID vaccine, and the Union Health Ministry and the Central Drugs Standard Control Organisation (CDSCO) have approved it under restricted use in case of emergencies as a booster dose for people ages 18 and above.

Read this article to get an overview of the new nasal vaccine, its benefits, dose, and side effects.

Also Read: Vaccines: Learn How They Work And What Common Side Effects They Cause

What Is iNCOVACC?

iNCOVACC is the world's first nasal vaccine designed for active immunization against coronavirus infection. It is an Adenoviral vector-based SARSCoV-2 vaccine intended for nasal usage only.

Key Features:
  • An intranasal vaccine triggers a robust immune response, which works to neutralize IgG, mucosal IgA, and T-cell responses.
  • A potent immune response at the site of infection (nasal mucosa) is vital for impeding both infections and the spreading of COVID
  • The nasal passage has an impressive potential for vaccines owing to the well-established immune system of the nasal mucosa
  • It is non-invasive and pain-free
  • It is easily administered and does not require trained professionals
  • There is no risk of needle-related injuries and infections
  • Good compliance
  • Supports meeting global demand

Who Are Eligible For The Nasal Vaccine?

The government of India has approved the administration of Bharat Biotech's intranasal vaccine, iNCOVACC, for people above 18 years of age. Further, it can be taken as a booster dose to adults who have taken 2 shots of either Covaxin or Covishield.

Also Read: Vaccines Work Against All Mutant Strains. Get Inoculated To Stay Safe

Who Should Not Get Incovacc?

You should not take iNCOVACC if you:

  • Have any allergic reactions to ingredients present in the vaccine
  • Had a bad allergic reaction after a previous shot of this vaccine
  • If you aresuffering from an acute infection or fever?

How Is The Nasal Vaccine Administered?

iNCOVACC is given via the nose in two doses taken within an interval of 4 weeks from the first dose. A total of 8 drops (0.5ml per dose) are administered,4 drops into each nostril.

What Information Should A Person Provide To The Healthcare Provider Before Getting iNCOVACC?

Inform the vaccinator or supervising officer about all your medication history, including if:

  • You are on regular drugs for any medical illness, duration, and for which health condition
  • You have any allergies
  • Have fever
  • If you are a person with a bleeding disorder or are on a blood thinner
  • If you are immunocompromised, are you on a medication that affects your immune system?
  • If you are pregnant
  • Have taken another COVID jab

What Are the Benefits Of iNCOVACC?

iNCOVACC nasal vaccine has undergone extensive trials, and a phase 3 clinical study done with 3000 participants has shown a positive impact and produced good immunity following 2 doses taken 4 weeks apart. However, it is important to note that getting the vaccine does not mean one should not follow other precautions related to coronavirus infection.

What Are The Side Effects Of iNCOVACC COVID-19 Vaccine?

Some of the side effects observed so far include:

  • Headache
  • Fever
  • Running nose
  • Sneezing

Rarely a severe allergic reaction may develop after getting a nasal vaccine; no such event was reported in the study period with iNCOVACC.

What Should I Do If I Experience Any Side Effects?

Well, if you exhibit any side effects, immediately contact or visit your health care provider or officer supervising vaccination or go to the nearest hospital. Moreover, one can also report side effects after immunization to Bharat Biotech International Limited, the manufacturer of iNCOVACC, on a 24*7 Toll-free number: 1800 102 2245.

Where Is The iNCOVACC Vaccine Available?

The nasal vaccine is now available at all private hospitals, and people can book appointments for COVID iNCOVACC booster doses via the Cowin app online from December 23, 2022.

How Much Does iNCOVACC Cost In India?

iNCOVACC vaccine costs Rs 800 for each dose in private hospitals. It will be used as a heterologous booster dose and will be available first in private hospitals. However, government officials have stated that it will also be included in the vaccination program.

*Source Fact Sheet -Bharat Biotech International Limited.